legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

## ANI Pharmaceuticals, Inc. Announces First Quarter 2024 Financial Results

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) recently shared that it will release its first quarter 2024 financial results on Friday, May 10, 2024, before the market opens. This announcement was made by Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer.

The conference call to discuss the results is scheduled as follows:

– **Date:** Friday, May 10, 2024
– **Time:** 8:30 a.m. ET
– **Toll-free (U.S.):** 800-274-8461
– **Conference ID:** 4555224
– **Webcast (live and replay):** www.anipharmaceuticals.com, under the “Investors” section

A replay of the conference call will be available within two hours of its completion and will be accessible for two weeks by dialing 800-938-2239 and entering access code 4555224.

### How AI legalese decoder Can Help

The AI legalese decoder can assist stakeholders in quickly and accurately understanding legal jargon often found in financial reports, conference calls, and other legal documents related to ANI Pharmaceuticals, Inc. By utilizing this tool, investors, analysts, and other interested parties can simplify complex legal language, ensuring a better comprehension of the company’s financial performance, strategies, and goals.

## About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to helping patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, particularly for diseases with unmet medical needs. The company aims to achieve sustainable growth by expanding its Rare Disease business, strengthening its Generics business, leveraging its U.S.-based manufacturing facilities, and innovating in Established Brands.

For more information on ANI Pharmaceuticals, Inc., please visit their website www.anipharmaceuticals.com.

### Investor Relations Contact

For any investor-related queries, reach out to Lisa M. Wilson at In-Site Communications, Inc., by calling 212-452-2793 or emailing [email protected].

**SOURCE:** ANI Pharmaceuticals, Inc.

By using the AI legalese decoder, stakeholders can gain a better understanding of ANI Pharmaceuticals, Inc.’s financial reports, conference calls, and other legal documents, enabling them to make informed decisions and assessments regarding the company’s performance and future prospects.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link